CNCE insider filings
CONCERT PHARMACEUTICALS, INC. — 11 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-06. Screen CNCE transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CNCE between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — CONCERT PHARMACEUTICALS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-03-06 | 4 | van Heek Christi — Director | Code (U): 25,651 · Disposition to issuer (D): 16,400 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +3 more | EDGAR |
| 2023-03-06 | 4 | Tung Roger D — Chief Executive Officer, Director | Code (U): 756,427 · Disposition to issuer (D): 57,916 · Code (U): 121,873 · Code (U): 13,274 · Code (U): 12,389 · Disposition to issuer (D): 156,675 (derivative) · +7 more | EDGAR |
| 2023-03-06 | 4 | Stuart Nancy — Chief Operating Officer | Code (U): 167,963 · Disposition to issuer (D): 73,233 · Disposition to issuer (D): 21,400 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 70,000 (derivative) · +4 more | EDGAR |
| 2023-03-06 | 4 | Munsie Jeffrey A — Chief Legal Officer | Code (U): 38,350 · Disposition to issuer (D): 49,699 · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 42,430 (derivative) · Disposition to issuer (D): 51,850 (derivative) | EDGAR |
| 2023-03-06 | 4 | Hoeiland Jesper — Director | Code (U): 5,125 · Disposition to issuer (D): 16,400 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,250 (derivative) | EDGAR |
| 2023-03-06 | 4 | Becker Marc A. — Chief Financial Officer | Code (U): 56,264 · Disposition to issuer (D): 49,699 · Disposition to issuer (D): 17,900 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 110,000 (derivative) · Disposition to issuer (D): 42,430 (derivative) · +1 more | EDGAR |
| 2023-03-06 | 4 | Auchincloss Thomas G — Director | Code (U): 17,625 · Disposition to issuer (D): 16,400 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +4 more | EDGAR |
| 2023-03-06 | 4 | Cassella James V — Chief Development Officer | Code (U): 80,595 · Disposition to issuer (D): 57,766 · Disposition to issuer (D): 34,700 (derivative) · Disposition to issuer (D): 140,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 70,000 (derivative) · +4 more | EDGAR |
| 2023-03-06 | 4 | JAEGER WILFRED E — Director | Code (U): 5,125 · Disposition to issuer (D): 16,400 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +3 more | EDGAR |
| 2023-03-06 | 4 | ALDRICH RICHARD — Director | Code (U): 342,100 · Disposition to issuer (D): 16,400 · Code (U): 210,526 · Code (U): 44,351 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +6 more | EDGAR |
| 2023-03-06 | 4 | HUTT PETER BARTON — Director | Code (U): 13,088 · Disposition to issuer (D): 16,400 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +3 more | EDGAR |
Recent 8-K events — CONCERT PHARMACEUTICALS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-03-06 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CNCE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →